22.40NOK0.00%Mkt Cap: 1.01B NOKP/E: 13.57Last update: 2026-05-13
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for th…
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 167.7
58.14BTRYP/E 27.8
51.02BEURP/E 20.1
13.68BEURP/E 31.2
13.35BTRY—
13.10BSEKP/E 39.5
3.09BTRY—
3.02BEURP/E 25.0
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)13.57
P/E (Forward)—
PEG—
P/B3.07
P/S2.25
EV/EBITDA9.05
EV/Revenue2.24
EPS (TTM)1.68
EPS (Forward)—
Cash Flow & Leverage
FCF Yield1.63%
FCF Margin3.68%
Operating CF78.04M NOK
CapEx (TTM)16.68M NOK
Net Debt/EBITDA-0.05
Net Debt-5.83M NOK
Technical
SMA 5022.03 (+1.7%)
SMA 20021.90 (+2.3%)
Beta0.62
S&P 52W Chg24.23%
Avg Vol (30d)26.74K
Avg Vol (10d)56.31K
Technical Indicators
RSI (14)51.6
MACD0.0828
MACD Signal0.1362
MACD Hist.-0.0534
BB Upper23.10 NOK
BB Middle22.53 NOK
BB Lower21.96 NOK
BB Width5.09%
ATR (14)0.5380 NOK
Vol Ratio (20d)0.11x
52W Range
19.4043% of range26.40
52W High26.40 NOK
52W Low19.40 NOK
Profitability
Gross Margin51.28%
EBITDA Margin24.71%
Profit Margin16.53%
Oper. Margin19.18%
ROE22.73%
ROA17.01%
Revenue Growth-2.50%
Earnings Growth-1.20%
Balance Sheet
Debt/Equity0.00
Current Ratio2.96
Quick Ratio1.83
Book Value/Sh7.415 NOK
Cash/Share0.1430 NOK
Dividends
Fwd Div Rate2.250 NOK
Trail. Div Rate1.500 NOK
Div. Yield9.87%
5Y Avg Yield—
Payout Ratio74.40%
Ex-Div DateMay 22, 2026
Pay Date—
Ownership
Shares Out.44.34M
Float21.97M
Insiders58.94%
Institutions13.74%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap1.01B NOK
Enterprise Value1.01B NOK
Revenue (TTM)449.47M NOK
Gross Profit231.95M NOK
Net Income (TTM)74.75M NOK
Revenue/Share10.13 NOK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees74
Last Price22.40 NOK
CountryNO
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—